Meeting
Abstract Number: 0153
SHM Converge 2025
Background: In 2019, the US Food & Drug Administration issued a warning regarding safety of gabapentin use in patients with respiratory conditions, including chronic obstructive pulmonary disease (COPD). Gabapentin is widely prescribed, often for off-label indications, however limited data exist regarding safety and outcomes among patients with COPD. Methods: We analyzed data from 29 US [...]
Abstract Number: 0159
SHM Converge 2025
Background: In the management of transplant-ineligible multiple myeloma (MM), therapeutic strategies are crucial for improving patient outcomes. Recent clinical trials have explored the efficacy of triplet vs dual therapy in this context. This meta-analysis aimed to evaluate the comparative effectiveness (overall survival [OS], progression-free survival [PFS], minimal residual disease [MRD] negative, and response rate [RR]) [...]
Abstract Number: 1041
SHM Converge 2025
Background: Burnout among hospital medicine physicians has been reported to be 50-60%, with prevalence likely increasing during the COVID-19 pandemic (1-3). Prior studies suggest burnout may be lower in the Veterans Administration (VA) compared to non-VA healthcare settings (4, 5). However, specific data examining burnout in VA Hospital Medicine (HM) physicians are lacking. To address [...]